# AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: AstraZeneca · Condition: Relapsed/Refractory Multiple Myeloma

- Company: AstraZeneca
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT05850234

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.